PubMed HealthSearch

PubMed · 2963285

[Delta hepatitis].

Abstract

Hepatitis delta virus is a small defective RNA virus that replicates only in the presence of hepatitis B virus. Delta infections occur in two circumstances: co-infections where both viruses are acquired simultaneously, and superinfections where delta virus infects a patient who is already a chronic carrier of hepatitis B virus. In both cases, delta virus may induce a more severe outcome of the disease. Diagnostic tests of delta infection have recently become available and should be used in all cases of acute hepatitis B occurring in populations at risk of delta infection such as intravenous-drug addicts. Prevention of delta infection is essentially based on immunization against hepatitis B of populations exposed to both viruses.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Goudeau, F Dubois, P Leturcq. 1987-12-12. [Delta hepatitis].. https://pubmed.ncbi.nlm.nih.gov/2963285/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of anti-HCV antibodies in immunoglobulin preparations by recombinant immunoblot assay.

The presence of anti-HCV antibodies in immunoglobulin preparations was investigated by recombinant immunoblot assay (RIBA) and enzyme immunoassay (EIA). While EIA was found to be suitable for detecting anti-HCV antibodies in immunoglobulin preparations, the RIBA could not be used without modifying the standard procedure developed for use with human sera. The two modifications were: (1) incubation with the anti-human IgG conjugate in a single test tube for each strip, instead of in a common vessel; (2) removal of the conjugate after 15 min and its replacement with fresh conjugate for a second 15 min incubation period. Thirty-six immunoglobulin preparations were tested using this modified procedure. Twenty-nine out of 31 (93.5%) preparations received in 1992 were anti-HCV positive, whereas the five immunoglobulin preparations received in 1993 were negative. These results were compared with those obtained on the same samples with the EIA. The percentage of samples positive with EIA was 74.2%. The difference between the results obtained with modified RIBA and EIA was statistically significant (P < 0.05).

Hepatitis Antibodies

[Lichen and liver].

Explore the source record for details and available documents.

Hepatitis Antibodies